Skip to main content

Table 4 Risk factors for death at 28 days in the subpopulation with candidemia (univariate analysis)

From: Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study

Variable

Dead (n = 39 patients)

Alive (n = 57 patients)

P value

Age, median (IQR)

64 (50–76)

57 (46–71)

0.318

SAPS II, median (IQR)

52 (43–63)

47 (37–63)

0.095

Male, n (%)

28 (71.8)

37 (64.9)

0.448

Medical admission, n (%)

30 (76.9)

31 (54.4)

0.038

Charlson comorbidity index score, n (%)

  

0.5816

 0

8 (20.5)

17 (29.8)

 

 1–2

17 (43.6)

20 (35.1)

 

 ≥3

14 (35.9)

20 (35.1)

 

At least one chronic illness, n (%)

16 (41)

24 (42.1)

0.982

 Immunosuppression, n (%)

8 (20.5)

7 (12.3)

0.271

 Cardiovascular, n (%)

3 (7.7)

11 (19.3)

0.1245

 Respiratory, n (%)

5 (12.8)

7 (12.3)

0.811

 Renal, n (%)

2 (5.1)

6 (10.5)

0.431

 Liver, n (%)

3 (7.7)

1 (1.8)

0.174

At least one organ dysfunction on admission, n (%)

37 (94.9)

49 (86)

0.187

 Cardiovascular, n (%)

25 (64.1)

36 (63.2)

0.901

 Respiratory, n (%)

34 (87.2)

45 (78.9)

0.284

 Neurologic, n (%)

13 (33.3)

15 (26.3)

0.375

 Renal, n (%)

9 (23.1)

15 (26.3)

0.752

Delay between ICU admission and fungemia, days, median (IQR)

8 (4–13)

10 (3–21)

0.229

Delay between hospital admission and fungemia, days, median (IQR)

20 (10–29)

21 (11–32)

0.591

Sepsis syndrome, n (%)

  

0.301

 Sepsis

3 (7.7)

11 (19.3)

 

 Severe sepsis

14 (35.9)

20 (35.1)

 

 Septic shock

22 (56.4)

26 (45.6)

 

SOFA, n (%)

  

0.004

 0–4

3 (7.7)

14 (24.6)

 

 5–7

6 (15.4)

18 (31.6)

 

 8–11

12 (30.8)

19 (33.3)

 

 ≥12

18 (46.2)

6 (10.5)

 

SOFA score, respiratory, n (%)

  

0.019

 0

4 (10.3)

8 (14)

 

 1

1 (2.6)

7 (12.3)

 

 2

8 (20.5)

23 (40.4)

 

 3

13 (33.3)

16 (28.1)

 

 4

13 (33.3)

3 (5.3)

 

SOFA score, cardiovascular, n (%)

  

0.015

 0

9 (23.1)

19 (33.3)

 

 1

4 (10.3)

12 (21.1)

 

 2

1 (2.6)

4 (7)

 

 3

4 (10.3)

13 (22.8)

 

 4

21 (53.8)

9 (15.8)

 

SOFA score, neurological, n (%)

  

0.249

 0

13 (33.3)

17 (29.8)

 

 1

5 (12.8)

14 (24.6)

 

 2

7 (17.9)

8 (14)

 

 3

4 (10.3)

11 (19.3)

 

 4

10 (25.6)

7 (12.3)

 

SOFA score, renal, n (%)

  

0.122

 0

11 (28.2)

32 (56.1)

 

 1

8 (20.5)

10 (17.5)

 

 2

5 (12.8)

5 (8.8)

 

 3

5 (12.8)

3 (5.3)

 

 4

10 (25.6)

7 (12.3)

 

SOFA score, coagulation, n (%)

  

0.125

 0

19 (48.7)

42 (73.7)

 

 1

6 (15.4)

3 (5.3)

 

 2

4 (10.3)

7 (12.3)

 

 3

6 (15.4)

4 (7)

 

 4

4 (10.3)

1 (1.8)

 

SOFA score, liver, n (%)

  

0.142

 0

26 (66.7)

46 (80.7)

 

 1

6 (15.4)

6 (10.5)

 

 2

1 (2.6)

4 (7)

 

 3

6 (15.4)

1 (1.8)

 

Need for mechanical ventilation, n (%)

37 (94.9)

47 (82.5)

0.094

Hypotension, n (%)

25 (64.1)

29 (50.9)

0.208

Presumed source of infection, n (%)

  

0.573

 No clear source

12 (30.8)

20 (35.1)

 

 Catheter-related

6 (15.4)

15 (26.3)

 

 Intra-abdominal

8 (20.5)

4 (7)

 

 Respiratory

6 (15.4)

8 (14)

 

 Urinary

2 (5.1)

2 (3.5)

 

 Others

2 (5.1)

4 (7)

 

 Multiple sources, n (%)

3 (7.7)

4 (7)

 

Delay of adequate treatment, n (%)

  

0.694

 <24 h

11 (28.2)

11 (19.3)

 

 >24 h and ≤48 h

9 (23.1)

14 (24.6)

 

 >48 h and ≤120 h

12 (30.8)

24 (42.1)

 

 >120 h or never

7 (17.9)

8 (14)

 

Antifungal treatment on the day of blood culture sampling, n (%)

8 (20.5)

8 (14)

0.491

Candida pathogen, n (%)

  

0.693

 Candida albicans

23 (59)

33 (57.9)

 

 Candida parapsilosis

5 (12.8)

5 (8.8)

 

 Other fungus

11 (28.2)

19 (33.3)

 
  1. SOFA Sequential Organ Failure Assessment